Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Archives of Internal Medicine

• Publication date

  1987-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.1987.00370050179030PMID 3579450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholestatic hepatitis after dicloxacillin-sodium therapy.

  1986cited by this paper
• Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis.

  1985cited by this paper
• Flucloxacillin-associated liver damage.

  1982cited by this paper
• Evaluation of prajmalium-induced cholestasis by immunologic tests.

  1981cited by this paper
• Cholestatic jaundice caused by cloxacillin: macrophage inhibition factor test in preventing rechallenge with hepatotoxic drugs.

  1980cited by this paper
• Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals.

  1980cited by this paper
• Hepatitis associated with high-dose oxacillin therapy.

  1978cited by this paper
• Oxacillin hepatitis. Two patients with liver biopsy, and review of the literature.

  1978cited by this paper
• Oxacillin-induced hepatic dysfunction.

  1973cited by this paper
• The treatment of infants with oxacillin sodium.

  1967cited by this paper
• Diagnosis of drug allergy in vitro with the lymphocyte transformation test.

  1967cited by this paper
• CHOLESTATIC HEPATITIS FOLLOWING THE ADMINISTRATION OF SODIUM OXACILLIN.

  1965cited by this paper

• O legado de Vasco Maria: uma vida com propósito e foco na saúde e no medicamento

  2023cites this paper
• Adverse Drug Reactions, still masquerading after all these years?

  2019cites this paper
• Drugs and Toxins

  2018cites this paper
• Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

  2013cites this paper
• Hepatotoxicity of antibiotics: a review and update for the clinician.

  2013cites this paper
• 13 – Hepatic injury due to drugs, herbal compounds, chemicals and toxins

  2012cites this paper
• Methodological Options for the Evaluation of Drug Safety: From Spontaneous Reports to Pharmacoepidemiology

  2008cites this paper
• Flucloxacillin-associated hepatic injury.

  2008cites this paper
• Penicillins, cephalosporins, other β-lactam antibiotics, and tetracyclines

  2007cites this paper
• Amoxycillin/clavulanic acid (augmentin)-induced intrahepatic cholestasis

  2005cites this paper
• Immunochemical detection of flucloxacillin adduct formation in livers of treated rats.

  2005cites this paper
• Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database.

  2005cites this paper
• Recurrent Cholestasis Due to Ampicillin

  2003cites this paper
• Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes.

  2001cites this paper
• Drug- and chemical-induced cholestasis.

  1999cites this paper
• Amoxicillin/Clavulanate-Associated Hepatic Failure with Progression to Stevens–Johnson Syndrome

  1999cites this paper
• IMMUNE MECHANISMS IN DRUG HEPATOTOXICITY

  1998cites this paper
• Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury

  1997cites this paper
• Drug-induced hepatocellular liver injury due to benzylpenicillin with evidence of lymphocyte sensitization.

  1997cites this paper
• [Hepatotoxicity caused by cloxacillin].

  1997cites this paper
• Development and validation of a clinical scale for the diagnosis of drug‐induced hepatitis

  1997cites this paper
• Drug-induced cholestasis.

  1997cites this paper
• [Antibiotic-induced prolonged cholestasis: suspected induction by ceftibuten].

  1996cites this paper
• Possible granulomatous hepatitis after dicloxacillin therapy.

  1996cites this paper
• Flucloxacillin associated cholestatic hepatitis

  1995cites this paper
• Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?

  1995cites this paper
• Hepatotoxicity of antimicrobial, antifungal, and antiparasitic agents.

  1995cites this paper
• Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis.

  1994cites this paper
• Lymphocyte proliferative response to drugs: Analysis of the value of a 24-well lymphocyte culture system.

  1994cites this paper
• Hepatic side-effects of antibiotics.

  1994cites this paper
• Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.

  1994cites this paper
• Prolonged jaundice after dicloxacillin therapy.

  1993cites this paper
• Flucloxacillin Induced Liver Disease: Histopathological Findings At Biopsy And Autopsy

  1993cites this paper
• Significance of abnormal liver function tests associated with administration of amoxicillin and other penicillins.

  1993cites this paper
• Cholestatic hepatitis associated with the use of nafcillin.

  1993cites this paper
• Cholestatic Hepatitis Associated with Flucloxacillin

  1993cites this paper
• Hypersensitivity Immune Reaction as a Mechanism for Dilevalol-Associated Hepatitis

  1992cites this paper
• Liver damage from flucloxacillin, cloxacillin and dicloxacillin.

  1992cites this paper
• Penicillins, cephalosporins and tetracyclines

  1991cites this paper
• [Hepatotoxicity of antimicrobial agents. I: Antibacterial antibiotics].

  1990cites this paper
• Drug-Induced Allergic Hepatitis

  1990cites this paper
• Cloxacillin-induced cholestasis in a renal allograft patient with chronic hepatitis.

  1990cites this paper
• [Cholestatic hepatitis induced by the amoxicillin-clavulanic acid combination. A case and review of the literature].

  1990cites this paper
• Flucloxacillin induced delayed cholestatic hepatitis.

  1990cites this paper
• Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin)

  1989cites this paper
• Prolonged hepatic cholestasis after flucloxacillin therapy

  1989cites this paper
• Amoxycillin/clavulanic acid (augmentin)-induced intrahepatic cholestasis

  1989cites this paper
• Delayed diagnosis of red‐back spider envenomation: a timely reminder (for editorial comment, see page 610; see also page 706)

  1989cites this paper
• Agranulocytosis and liver damage associated with pyrazinobutazone with evidence for an immunological mechanism.

  1989cites this paper
• The immunologic and metabolic basis of drug hypersensitivities.

  1988cites this paper
• 9 Drug-induced cholestasis

  1988cites this paper
• Drug-induced cholestasis.

  1988cites this paper